Hargreave Hale AIM VCT

Funding rounds backed by Hargreave Hale AIM VCT.

Export CSV
Funding disclosed in full
$20M
Median round
$20M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Qureight

End-to-end imaging company for clinical trials with a focus on lung and heart disease.

$20MSeries BHealthtechUnited Kingdom
6 participantsAscensionGuinness VenturesHargreave Hale AIM VCTMeltwindMolten VenturesXTX Ventures